Predictive Oncology Inc. (NASDAQ: POAI) Subsidiary’s CIO Discusses Curing Cancer with AI on …

… personalized medicine and drug discovery, announced that one of its executives, Helomics CIO Mark Collins, PhD, recently appeared on DojoLIVE!
read source